Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.

NCT02064699 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT02064699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02064699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.
Lead sponsor
University Hospital, Limoges
Phase
Observational
Overall status
Terminated
Start date
May 31, 2013
Completion date
December 13, 2017
Enrollment
75 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

immunized against the cytomegalovirus, renal transplant recipient